Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAsa Int Regulatory News (ASAI)

Share Price Information for Asa Int (ASAI)

Share Price is delayed by 15 minutes
Get Live Data
196.00    -10.00 (-4.85%)
Bid:
195.50
Ask:
202.00
Spread: 6.50 (3.325%)
Market Cap: £191.70m
ASAI Live PriceLast checked at - London Stock Exchange

Intraday Asa Int Share Chart

Appointment of Independent Non-Executive Director

28 Apr 2026 07:00

RNS Number : 0362C
ASA International Group PLC
28 April 2026
 
28 April 2026ASA International Group plc - Appointment of Independent Non-Executive Director

ASA International Group plc (LSE: ASAI), one of the world's largest international microfinance institutions, is today pleased to announce the appointment of Ms Laurence de l'Escaille as an Independent Non-Executive Director.

Laurence will become a member of the Audit and Risk Committee, the Remuneration Committee, Nomination Committee and the Independent Directors Committee of the Board.

Laurence de l'Escaille is an experienced board director with a strong background in strategy, corporate finance, and governance across regulated financial services, energy, and infrastructure sectors. She brings extensive emerging markets experience and has served on the boards of major listed and regulated institutions in Europe.

Laurence currently serves as an independent board member of BNP Paribas Fortis, where she is a member of the Audit Committee, Remuneration Committee, and Governance & Nomination Committee. She previously served as Chair of the Remuneration Committee at bpost bank during its integration into BNP Paribas Fortis. She was also an independent board member of Elia Group and Elia Transmission Belgium. In addition, Laurence is an independent member of the Belgian Commission for Nuclear Provisions, which oversees long term funding for nuclear decommissioning and spent fuel management in Belgium.

Previously, Laurence was a Partner at McKinsey & Company, advising governments, financial institutions, and energy companies across Europe, the United States, and Africa for over 8 years. She has also held roles at the International Monetary Fund and advised the Belgian federal government, where she led strategy for Belgium's national COVID 19 vaccination rollout. Laurence holds degrees from the University of Oxford and Johns Hopkins University, and postgraduate qualifications in economics, corporate finance, and psychology.

This announcement is made pursuant to Listing Rule 6.4.6R. In accordance with LR 6.4.8R, the Company confirms that there is no information to be disclosed in terms of LR 6.4.8R (1) to LR 6.4.8R (6) inclusive in respect to Laurence de l'Escaille.

Contact Details

ASA International Group plc

Investor RelationsJonathan Berger ir@asa-international.com

About ASA International Group plc

ASA International Group plc (LSE: ASAI) is one of the world's largest international microfinance institutions, with a strong commitment to financial inclusion and socioeconomic progress. The company provides small, socially responsible loans to low-income, financially underserved entrepreneurs, predominantly women, across South Asia, South East Asia, West and East Africa.

Disclaimer

'ASA International', the 'Company', the 'Group' all refer to ASA International Group plc and its subsidiaries.

This announcement does not constitute or form part of any offer or invitation to purchase, otherwise acquire, issue, subscribe for, sell or otherwise dispose of any securities, nor any solicitation of any offer to purchase, otherwise acquire, issue, subscribe for, sell, or otherwise dispose of any securities. The release, publication or distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this announcement is released, published or distributed should inform themselves about and observe such restriction.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAMZGZDLNKGVZG
Date   Source Headline
9th Jun 20268:34 amRNSFTSE All Share Index Inclusion
3rd Jun 20262:14 pmRNSResult of 2026 Annual General Meeting
21st May 20267:00 amRNSDirector/PDMR Shareholding
6th May 20262:56 pmRNSDirector/PDMR Shareholding
5th May 20267:00 amRNSAppointment of Chairman and Board Update
30th Apr 20267:00 amRNSNotice of Annual General Meeting
30th Apr 20267:00 amRNSQ1 2026 Business Update
28th Apr 20267:00 amRNSAppointment of Independent Non-Executive Director
15th Apr 20267:00 amRNSFY 2025 Results
24th Feb 20267:00 amRNSDirector/PDMR Shareholding
6th Feb 20267:00 amRNSDirector/PDMR Shareholding
30th Jan 20261:31 pmRNSDirector/PDMR Shareholding
29th Jan 20267:00 amRNSQ4 2025 Trading and Business Update
13th Jan 20263:31 pmRNSHolding(s) in Company
9th Jan 20261:50 pmRNSDirector/PDMR Shareholding
9th Jan 20261:49 pmRNSDirector/PDMR Shareholding
19th Dec 202511:15 amRNS2025 Annual General Meeting Update Statement
19th Dec 202511:15 amRNS2025 Annual General Meeting Update Statement
17th Dec 20253:35 pmRNSAppointment of Non-Executive Director
4th Dec 20257:00 amRNSTrading Update
28th Nov 20259:36 amRNSHolding(s) in Company
10th Nov 20257:57 amRNSDirector/PDMR Shareholding
7th Nov 20259:38 amRNSHolding(s) in Company
6th Nov 20257:00 amRNSCFO Appointment
5th Nov 20255:31 pmRNSHolding(s) in Company
5th Nov 20255:27 pmRNSDirector/PDMR Shareholding
28th Oct 20252:20 pmRNSGrant of Options
27th Oct 20254:44 pmRNSDirector/PDMR Shareholding
21st Oct 20257:00 amRNSQ3 2025 Business Update
10th Oct 20253:29 pmRNSHolding(s) in Company
10th Oct 20253:28 pmRNSHolding(s) in Company
8th Oct 202512:44 pmRNSHolding(s) in Company
24th Sep 20257:00 amRNS2025 Interim Results
11th Aug 202512:20 pmRNSDirector/PDMR Shareholding
30th Jul 20254:32 pmRNSHolding(s) in Company
29th Jul 202511:12 amRNSHolding(s) in Company
23rd Jul 20259:40 amRNSDirector/PDMR Shareholding
22nd Jul 20257:00 amRNSQ2 2025 Business Update
19th Jun 20252:13 pmRNSResult of AGM
6th Jun 20257:00 amRNSDirectorate Change
20th May 20257:00 amRNSNotice of Annual General Meeting
24th Apr 20257:00 amRNS2024 Results
24th Apr 20257:00 amRNSAppointment of Independent Non-Executive Director
24th Apr 20257:00 amRNSQ1 2025 Business Update
20th Mar 20257:00 amRNSBoard and Leadership Update
10th Mar 202511:18 amRNSHolding(s) in Company
5th Mar 20254:27 pmRNSNotification of Major Holdings
5th Mar 20254:23 pmRNSNotification of Major Holdings
21st Jan 20257:00 amRNSQ4 2024 Trading and Business Update
8th Jan 20252:46 pmRNSDirector Remuneration Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.